3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Breast
1
Conditions
Breast Neoplasms
6
Endometrial Neoplasms
3
Uterine Cervical Neoplasms
2
Carcinoma, Intraductal, Noninfiltrating
2
Triple Negative Breast Neoplasms
1
Pediatric Patients With Solid Tumors
1
Lymphedema
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Eyelid Sebaceous Gland Carcinoma
1
Cervical Adenocarcinoma
1
Carcinoma, Ductal
1
Breast Neoplasms, Male
1
Breast Carcinoma In Situ
1
Interventions
Tamoxifen
6
Radiotherapy
3
Anastrozole
3
Taxes
2
Simvastatin
2
Radiation
2
Paclitaxel
2
Neoadjuvant Therapy
2
Letrozole
2
Gene Expression Profiling
2
Chemotherapy, Adjuvant
2
Celecoxib
2
telapristone acetate
1
poly(I).poly(c12,U)
1
oxybutynin
1
liposomal doxorubicin
1
exemestane
1
dexamethasone acetate
1
dexamethasone 21-phosphate
1
auricularum
1
Yoga
1
Sugars
1
Sentinel Lymph Node Biopsy
1
Ranitidine
1
Radiation Dose Hypofractionation
1
Pharmacogenomic Testing
1
Naltrexone
1
Monitoring, Physiologic
1
Mometasone Furoate
1
Metformin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Has results
×
Breast Carcinoma In Situ
×
Sentinel Lymph Node Biopsy
×
Clear all
NCT01841749
2025-09-12
CINNAMOME
Institut Bergonié
Completed
228 enrolled
4 charts